Quantcast

Latest Tranzyme Pharma Stories

2008-10-16 06:00:10

Tranzyme Pharma, a biopharmaceutical company engaged in the discovery and clinical development of first-in-class small molecule therapeutics, announced that Dr.

2008-10-01 06:00:29

Tranzyme Pharma today announced positive Phase IIb results for its first-in-class, highly potent and selective ghrelin agonist, TZP-101, for the management of postoperative ileus (POI).

2008-07-22 06:00:17

Tranzyme Pharma, a leading biopharmaceutical company developing novel mechanism-based therapeutics for the treatment of gastrointestinal (GI) and metabolic disorders, announced today that the Company has received Notices of Allowance from the U.S.

2008-06-25 06:03:22

Tranzyme Pharma has reported positive results from a 'thorough QT/QTc' study of its lead product TZP-101, an intravenous gastrointestinal prokinetic agent currently in two Phase IIb trials for the treatment of postoperative ileus and severe gastroparesis.

2008-06-23 06:00:06

Tranzyme Pharma announces the successful results from a "Thorough QT/QTc" study of the company's lead product TZP-101, an intravenous gastrointestinal prokinetic agent currently in two Phase IIb trials for the treatment of postoperative ileus (POI) and severe gastroparesis.

2008-06-17 06:00:07

Tranzyme Pharma announced today the successful completion of a Phase I, placebo-controlled, single ascending dose study of its orally administered ghrelin agonist, TZP-102. TZP-102 is the second drug candidate from Tranzyme's internal R&D efforts to reach clinical development.

2008-05-06 06:00:47

Tranzyme Pharma today announced that Dr. Philippa Charlton has joined the Company as Medical Director, Clinical Development, a newly created position. In this new position, Dr.


Word of the Day
shavie
  • A trick or prank.
The word 'shavie' is related to 'shave'.